Czechia medical psilocybin

Domain VII · Transpersonal, psychedelic & altered states · Horáček, Páleníček, Tylš · 2025 · Czechia

What it is

This is a regulated-access programme, not a distinct psychotherapy school. Since 1 January 2026, Czech law lets an individually prepared medicinal product containing psilocybin be prescribed and given in authorised healthcare settings. It may be used only for defined severe conditions, only after…

Format

• (c) Sudden deterioration of another severe neuropsychiatric or mental disorder that seriously threatens life, where use is scientifically justified. Requirements: at least two failed standard treatments (one in very severe cases), at least six months' duration, and at least one randomised trial or…
• Programme guarantor: psychiatrist or clinical psychologist with at least five years of PAP or ketamine-assisted psychotherapy (KAP) practice, at least 50 sessions and at least 30 hours of supervision.

Who practises it, and how they are trained or regulated

• Indications (all require documented failure of, or intolerance to, registered treatments):
• Supervising physician (lékař zajišťující zvláštní dohled): psychiatrist, or a palliative-care physician or a physician with the special qualification in medical psychotherapy, in either case with PAP postgraduate training. A doctor who has finished the psychiatry core may serve under supervision, with a qualified expert reachable within five minutes. Responsible for medical monitoring, acute interventions, discharge…
• Main accompanying therapist (hlavní provázející terapeut): psychiatrist, physician with medical-psychotherapy qualification, or clinical psychologist. Must hold an approved comprehensive psychotherapy training for healthcare and PAP postgraduate training. Health psychologists and physicians may serve under direct supervision.

Evidence status, as the guide reports it

• (a) Depressive disorder associated with cancer, especially existential distress. The guideline cites the strongest evidence here.

Questions to explore with your client

• What drew you to it, and what are you hoping it will change?
• Is there physical contact? Was it explained beforehand, and do you feel free to say no or stop at any point?
• Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
• Does it involve intense or unusual breathing? Have you been told about the medical conditions for which that is not advised?
• Is it a group, retreat or community? How do they respond if someone wants to leave or raises a concern?
• Who runs it, and what training or registration do they hold?
• What actually happens in a session or meeting, and how often?
• What does it cost, and is there pressure to commit to more?
• How do you feel afterwards, in the hours and days that follow?
• Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

• a missing escort (postpone); undisclosed substance use.
• music experienced as intrusive or manipulative; offer silence.
• apparent calm masking distress; elation driving plans to act on new insights straight away.
• breath-holding, hyperventilation or tingling (switch to external anchors and tell the physician).
• intrusive trauma memories during practice (pace it, stabilise, and tell the indicating psychiatrist).

When to involve someone else

• New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
• Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
• A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.